1478. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS

Lignende værker

• 2722 B. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS
  af: Quiambao, Beatriz, et al.
  Udgivet: (2019)
• Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
  af: Vesikari, Timo, et al.
  Udgivet: (2020)
• Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents
  af: Quiambao, Beatriz P., et al.
  Udgivet: (2016)
• 4. MenACWY-TT Long-Term Antibody Persistence Following Adolescent Vaccination and Evaluation of a Booster Dose: A Review of Clinical Data
  af: Peyrani, Paula, et al.
  Udgivet: (2020)
• A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years
  af: Borja-Tabora, Charissa Fay Corazon, et al.
  Udgivet: (2020)